In AbetaPP-overexpressing cultured human muscle fibers proteasome inhibition enhances phosphorylation of AbetaPP751 and GSK3beta activation: effects mitigated by lithium and apparently relevant to sporadic inclusion-body myositis.
In AbetaPP-overexpressing cultured human muscle fibers proteasome inhibition enhances phosphorylation of AbetaPP751 and GSK3beta activation: effects mitigated by lithium and apparently relevant to sporadic inclusion-body myositis.
复制标题
DOI:
10.1111/j.1471-4159.2009.06461.x
复制
发表时间:
2010-01
影响因子:
4.7
通讯作者:
Askanas V
中科院分区:
文献类型:
--
作者:
Terracciano C;Nogalska A;Engel WK;Askanas V
Muscle fiber degeneration in sporadic inclusion-body myositis (s-IBM) is characterized by accumulation of multiprotein aggregates, including aggregated amyloid-β-precursor protein 751 (AβPP751), amyloid-β (Aβ), phosphorylated tau (p-tau), and other “Alzheimer-characteristic” proteins. Proteasome inhibition is an important component of the s-IBM pathogenesis. In brains of Alzheimer disease (AD) patients and AD transgenic mouse models, phosphorylation of neuronal AβPP695 (p-AβPP) on Threonine668 (T668) (equivalent to T724 of AβPP751) is considered detrimental because it increases generation of cytotoxic Aβ and induces tau phosphorylation. Activated glycogen synthase kinase3β (GSK3β) is involved in phosphorylation of both AβPP and tau. Lithium, an inhibitor of GSK3β, was reported to reduce levels of both the total AβPP and p-AβPP in AD animal models. In relation to s-IBM, we now show for the first time that: 1. In AβPP-overexpressing cultured human muscle fibers (human muscle culture IBM model: a) proteasome inhibition significantly increases GSK3β activity and AβPP phosphorylation; b) treatment with lithium decreases i) phosphorylated-AβPP; ii) total amount of AβPP, iii) Aβ oligomers, and iv) GSK3β activity; and c) lithium improves proteasome function. 2. In biopsied s-IBM muscle fibers, GSK3β is significantly activated and AβPP is phosphorylated on Thr724. Accordingly, treatment with lithium, or other GSK3β inhibitors, might benefit s-IBM patients.
登录
查看更多内容
DOI:
10.1083/jcb.200301115
发表时间:
2003-10-13
期刊:
The Journal of cell biology
影响因子:
--
作者:
Lee MS;Kao SC;Lemere CA;Xia W;Tseng HC;Zhou Y;Neve R;Ahlijanian MK;Tsai LH
通讯作者:
Tsai LH
影响因子:
6
作者:
Fratta, P;Engel, WK;Askanas, V
通讯作者:
Askanas, V
影响因子:
16
作者:
Lochhead, Pamela A.;Kinstrie, Ross;Cleghon, Vaughn
通讯作者:
Cleghon, Vaughn
DOI:
10.1523/jneurosci.1150-09.2009
发表时间:
2009-05-13
期刊:
The Journal of neuroscience : the official journal of the Society for Neuroscience
影响因子:
--
作者:
Kitazawa M;Vasilevko V;Cribbs DH;LaFerla FM
通讯作者:
LaFerla FM
影响因子:
6
作者:
Jin, LW;Hearn, MG;Martin, GM
通讯作者:
Martin, GM